Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of FDA Orange Book Patents covering Levocetirizine

Client Email

Product

Levocetirizine
CAS 109806-71-5
CAS 303-26-4
Cetirizine
Cetirizine Dihydrochloride
US Patents

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Levocetirizine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

51 API Suppliers, 14 USDMF, 1 CEP/COS, 4 JDMF, 17 EU WC, 22 KDMF, 17 NDC API, 38 Listed Suppliers, $ API Reference Price

51 API Suppliers
14 USDMF
1 CEP/COS
4 JDMF
17 EU WC
22 KDMF
17 NDC API
38 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

INTERMEDIATES

9 API Suppliers

9 API Suppliers

FINISHED DOSAGE FORMULATIONS

216 FDF Dossiers, 29 FDA Orange Book, 60 Europe, 39 South Africa, 88 Listed Dossiers

216 FDF Dossiers
29 FDA Orange Book
60 Europe
39 South Africa
88 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;ORAL - 2.5MG/5ML, TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - 2.5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;ORAL - 2.5MG/5ML
TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;ORAL - 2.5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 1 SPI Pharma, 2 Seqens, 5 DKSH, 2 Jai Radhe Sales, 1 Pharm-RX Chemical, 10 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 10 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 BASF, 1 Bioplus Life Sciences, 1 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 1 Finar, 9 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 35 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 17 Roquette, 12 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 The Dow Chemical Company, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

54 Fillers, Diluents & Binders, 47 Coating Systems & Additives, 24 Thickeners and Stabilizers, 24 Controlled & Modified Release, 23 Direct Compression, 15 Solubilizers, 15 Disintegrants & Superdisintegrants, 14 Granulation, 14 Film Formers & Plasticizers, 13 Taste Masking, 13 Co-Processed Excipients, 12 Topical, 12 Parenteral, 11 Lubricants & Glidants, 7 Emulsifying Agents, 5 API Stability Enhancers, 5 Rheology Modifiers, 5 Empty Capsules, 4 Coloring Agents, 4 Chewable & Orodispersible Aids, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents

54 Fillers, Diluents & Binders
47 Coating Systems & Additives
24 Thickeners and Stabilizers
24 Controlled & Modified Release
23 Direct Compression
15 Solubilizers
15 Disintegrants & Superdisintegrants
14 Granulation
14 Film Formers & Plasticizers
13 Taste Masking
13 Co-Processed Excipients
12 Topical
12 Parenteral
11 Lubricants & Glidants
7 Emulsifying Agents
5 API Stability Enhancers
5 Rheology Modifiers
5 Empty Capsules
4 Coloring Agents
4 Chewable & Orodispersible Aids
4 Vegetarian Capsules
3 Surfactant & Foaming Agents

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 24 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
24 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 59 Finished Drug Prices, 7 Annual Reports

1 US Medicaid Prescriptions
59 Finished Drug Prices
7 Annual Reports

MARKET PLACE

41 APIs, 5 FDF Dossiers

41 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Patents

1 US Patents

REF. STANDARDS & IMPURITIES

2 USP, 9 Others

2 USP
9 Others

ANALYTICAL

4 BioAnalytical Methods

4 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 663 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

1 All

01 1CHATTEM SANOFI

filter Patent Number Reset all filters

1 All

01 18633194

filter API Patent Reset all filters

1 All

01 1Blank

filter FDF Patent Reset all filters

1 All

01 1Y

filter Expiration Date Reset all filters

1 All

01 12027-10-16

Product Main Page

01

CHATTEM SANOFI

LEVOCETIRIZINE DIHYDROCHLORIDE

Formnext Forum

Not Confirmed

CHATTEM SANOFI

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-10-16

LEVOCETIRIZINE DIHYDROCHLORIDE

US Patent Number : 8633194

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209090

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-10-16

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?